TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06830265: Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

Sponsor: Uro-1 Medical · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 200 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT06830265 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06830265 Rescue Dossier →